Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythromycin pharmacokinetics in man

G Houin, J P Tillement, F Lhoste

    The Journal of International Medical Research
    |January 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Distribution and antimicrobial susceptibility of bacteria from adults with community-acquired pneumonia or complicated skin and soft tissue infections in France: the nationwide French PREMIUM study.

    Diagnostic microbiology and infectious disease·2015
    Same author

    [8th Descartes-Berkeley interuniversity symposium on health economics, May 2013, Paris, France: an overview].

    Annales pharmaceutiques francaises·2013
    Same author

    [Trust-based economics with medicine outcome-based pricing].

    Annales pharmaceutiques francaises·2013
    Same author

    [Activity of doripenem against anaerobic bacteria].

    Pathologie-biologie·2010
    Same author

    Modification of aflatoxin B1 and ochratoxin A toxicokinetics in rats administered a yeast cell wall preparation.

    Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment·2010
    Same author

    [European requirements in microbiological evaluation of antibiotics].

    Medecine et maladies infectieuses·2008
    Same journal

    Clinical efficacy and electromyographic analysis of direct current hydrotherapy in the treatment of upper limb peripheral nerve injuries: A randomized controlled trial.

    The Journal of international medical research·2026
    Same journal

    Tacrolimus intrapatient variability and latent virus reactivation after kidney transplantation: A retrospective study comparing prolonged-release and immediate-release tacrolimus formulations.

    The Journal of international medical research·2026
    Same journal

    Dexmedetomidine for the prevention of postoperative atrial fibrillation: A systematic review and meta-analysis.

    The Journal of international medical research·2026
    Same journal

    Causal effects of blood and urinary biomarkers on cancer risk: A Mendelian randomization study.

    The Journal of international medical research·2026
    Same journal

    Autophagy-related pathway dysregulation and apoptosis suppression in pterygium: Role of key biomarkers Beclin-1, ATG5, LC3, p62, and Bcl-2 in pathogenesis and potential nonsurgical targets.

    The Journal of international medical research·2026
    Same journal

    Clinical efficacy and safety of icodextrin dialysate for overnight dwell in continuous ambulatory peritoneal dialysis: A prospective self-controlled study.

    The Journal of international medical research·2026
    See all related articles

    High serum concentrations of erythromycin are achieved with ethylsuccinate or lactobionate forms. However, a short half-life necessitates repeated dosing or continuous infusion for sustained efficacy.

    Area of Science:

    • Pharmacology
    • Infectious Diseases

    Background:

    • Erythromycin is a widely used antibiotic.
    • Understanding its pharmacokinetic profile is crucial for effective treatment.

    Purpose of the Study:

    • To evaluate serum concentrations and elimination half-life of erythromycin following different administration routes.
    • To determine optimal dosing strategies for maintaining therapeutic efficacy.

    Main Methods:

    • Administration of erythromycin ethylsuccinate and lactobionate formulations.
    • Measurement of serum erythromycin concentrations over time.
    • Calculation of elimination half-life.

    Main Results:

    • Both erythromycin ethylsuccinate and lactobionate achieved high initial serum concentrations.

    Related Experiment Videos

  • A short elimination half-life was observed for erythromycin.
  • Repetitive administration is implied for sustained therapeutic levels.

    • Conclusions:

    • Erythromycin ethylsuccinate and lactobionate effectively reach high serum levels.
    • The short elimination half-life of erythromycin suggests that continuous infusion may be the optimal method for maintaining efficacy.
    • Further studies on continuous infusion protocols are warranted.